Ventricles as a major site of atrial natriuretic factor synthesis and release in cardiomyopathic hamsters with heart failure.
- 1 July 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Circulation Research
- Vol. 65 (1) , 71-82
- https://doi.org/10.1161/01.res.65.1.71
Abstract
The aim of the present study was to correlate in cardiomyopathic hamsters with congestive heart failure the levels of atrial and ventricular atrial natriuretic factor (ANF) messenger RNA (mRNA) with immunoreactive ANF (IR-ANF) plasma levels and the relative amount of IR-ANF released by the whole heart versus isolated ventricles in the Langendorff preparation. High-performance liquid chromatography analysis of the forms of ANF present in plasma and in the Langendorff effluent of whole heart versus isolated ventricles was also performed. As previously found for cardiac IR-ANF, the levels of ANF mRNA decreased gradually in atria and increased in an analogous fashion in ventricles with the severity of congestive heart failure. Plasma IR-ANF levels (C-terminal) were more elevated in moderate than in severe congestive heart failure, as were the IR-ANF levels in the Langendorff effluent of the whole heart. On the contrary, the effluent of isolated ventricles from animals in severe heart failure yielded more IR-ANF than that from hamsters in moderate heart failure. Thus, while the isolated ventricles from controls contributed 35.8% of IR-ANF released by the whole heart, ventricles from hamsters in moderate heart failure contributed 17.5%, and those from hamsters in severe heart failure contributed 73.9%. These results indicate that atrial cardiocytes contribute more IR-ANF than their ventricular counterpart in moderate heart failure and that ventricles are a major source of plasma IR-ANF in severe heart failure. Analysis of IR-ANF from plasma and the Langendorff effluent from whole hearts and isolated ventricles revealed that the ventricles are the major source of the propeptide (and of its cleaved products) found in the circulation of cardiomyopathic hamsters. These results suggest that ANF synthesis and secretion do not increase conjointly in atria but do increase in ventricles during congestive heart failure.This publication has 60 references indexed in Scilit:
- Effects of steroid and thyroid hormones on synthesis of atrial natriuretic peptide by cultured atrial myocytes of ratBiochemical and Biophysical Research Communications, 1987
- Synthesis and presence of atrial natriuretic factor in rat ventricleBiochemical and Biophysical Research Communications, 1986
- Atrial natriuretic peptide mRNA is regulated by glucocorticoids invivoBiochemical and Biophysical Research Communications, 1986
- The phorbol ester induced atrial natriuretic peptide secretion is stimulated by forskolin and bay K8644 and inhibited by 8-bromo-cyclicGMPBiochemical and Biophysical Research Communications, 1986
- Bay K 8644, a voltage-sensitive calcium channel agonist, facilitates secretion of atrial natriuretic polypeptide from isolated perfused rat heartsBiochemical and Biophysical Research Communications, 1986
- Atriopeptin release in conditions of altered salt and water balance in the ratBiochemical and Biophysical Research Communications, 1986
- Atriopeptin: A Cardiac Hormone Intimately Involved in Fluid, Electrolyte, and Blood-Pressure HomeostasisNew England Journal of Medicine, 1986
- Release of atriopeptin in the rat by vasoconstrictors or water immersion correlates with changes in right atrial pressureBiochemical and Biophysical Research Communications, 1985
- Identification of a biologically active circulating form of rat atrial natriuretic factorBiochemical and Biophysical Research Communications, 1985
- Effect of different anesthetics on immunoreactive atrial natriuretic factor concentrations in rat plasmaBiochemical and Biophysical Research Communications, 1985